# FOXC1 Regulates Cytokine Signaling, Inflammatory Pathways, and Retinoid Metabolism to Maintain Limbal Epithelial Cell Homeostasis In Vitro

**Authors:** Swarnali Kundu, Maryam Amini, Tanja Stachon, Fabian Norbert Fries, Berthold Seitz, Zhen Li, Shuailin Li, Shanhe Liu, Shao-Lun Hsu, Shweta Suiwal, Nóra Szentmáry

PMC · DOI: 10.3390/ijms27041873 · International Journal of Molecular Sciences · 2026-02-15

## TL;DR

This study shows that FOXC1 helps maintain eye surface cell health by regulating inflammation, cell differentiation, and retinoid metabolism.

## Contribution

The study reveals FOXC1's role in regulating inflammatory and retinoid pathways in limbal epithelial cells.

## Key findings

- FOXC1 silencing reduced epithelial markers KRT12 and KRT13 at mRNA and protein levels.
- FOXC1 knockdown altered inflammatory signaling, reducing IL-6 and IL-8 mRNA but increasing IL-1α.
- Genes involved in retinoid metabolism were significantly downregulated with reduced protein levels.

## Abstract

This study aimed to evaluate FOXC1-mediated regulatory mechanisms on gene and protein expression profiles in primary human limbal epithelial cells (pLECs) using siRNA-mediated FOXC1 knockdown under basal conditions and following lipopolysaccharide (LPS) and interleukin-1β (IL-1β)-induced inflammatory conditions. The gene expression related to inflammation, epithelial differentiation, cell proliferation and remodeling, and retinoic acid metabolism was analyzed using qPCR. Corresponding protein levels were assessed through Western blotting and ELISA. FOXC1 silencing significantly downregulated epithelial differentiation markers KRT12 and KRT13 at the mRNA and protein levels (p ≤ 0.045), whereas KRT3 and KRT19 were unaffected. Inflammatory signaling was markedly altered, with a reduced IL-6 and IL-8 mRNA expression (p ≤ 0.029), increased IL-1α expression (p ≤ 0.015), and condition-dependent changes in IL-6 and IL-8 protein secretion. CCL2 was increased at the mRNA level only (p = 0.007). VEGFA mRNA was consistently reduced (p ≤ 0.022) without corresponding protein changes, while TGF-β protein was increased under non-inflammatory and LPS conditions (p ≤ 0.011). Genes involved in retinoid metabolism, including CYP1B1, FABP5, CRABP2, RDH10, STRA6, and ALDH3A1, were significantly downregulated (p ≤ 0.037), with reduced CRABP2 and RDH10 protein levels (p ≤ 0.017) and a decreased FABP5/CRABP2 ratio under IL-1β stimulation (p = 0.006). FOXC1 knockdown affected proliferation-related genes, with decreased FOSL2 (p = 0.048) and increased MKi67 (p = 0.006). FOXC1 silencing disrupts epithelial differentiation, inflammatory signaling, retinoid metabolism, and selected proliferation-related pathways at the transcriptional level, with more selective effects on protein levels. Such changes may potentially predispose the ocular surface to lineage instability, fibrosis, and impaired regenerative capacity.

## Linked entities

- **Genes:** FOXC1 (forkhead box C1) [NCBI Gene 2296], KRT12 (keratin 12) [NCBI Gene 3859], KRT13 (keratin 13) [NCBI Gene 3860], KRT3 (keratin 3) [NCBI Gene 3850], KRT19 (keratin 19) [NCBI Gene 3880], CYP1B1 (cytochrome P450 family 1 subfamily B member 1) [NCBI Gene 1545], FABP5 (fatty acid binding protein 5) [NCBI Gene 2171], CRABP2 (cellular retinoic acid binding protein 2) [NCBI Gene 1382], RDH10 (retinol dehydrogenase 10) [NCBI Gene 157506], STRA6 (signaling receptor and transporter of retinol STRA6) [NCBI Gene 64220], ALDH3A1 (aldehyde dehydrogenase 3 family member A1) [NCBI Gene 218], FOSL2 (FOS like 2, AP-1 transcription factor subunit) [NCBI Gene 2355], MKI67 (marker of proliferation Ki-67) [NCBI Gene 4288]
- **Proteins:** IL6 (interleukin 6), CXCL8 (C-X-C motif chemokine ligand 8), IL1A (interleukin 1 alpha), CCL2 (C-C motif chemokine ligand 2), VEGFA (vascular endothelial growth factor A), TGFB1 (transforming growth factor beta 1), CRABP2 (cellular retinoic acid binding protein 2), RDH10 (retinol dehydrogenase 10), FABP5 (fatty acid binding protein 5)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, PAX6 (paired box 6) [NCBI Gene 5080] {aka AN, AN1, AN2, ASGD5, D11S812E, FVH1}, KRT10 (keratin 10) [NCBI Gene 3858] {aka BCIE, BIE, CK10, EHK, EHK2, EHK2A}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, Sox2 (SRY (sex determining region Y)-box 2) [NCBI Gene 20674] {aka Sox-2, lcc, ysb}, CRABP2 (cellular retinoic acid binding protein 2) [NCBI Gene 1382] {aka CRABP-II, RBP6}, DSG1 (desmoglein 1) [NCBI Gene 1828] {aka CDHF4, DG1, DSG, EPKHE, EPKHIA, PPKS1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, TWIST1 (twist family bHLH transcription factor 1) [NCBI Gene 7291] {aka ACS3, BPES2, BPES3, CRS, CRS1, CSO}, Cxcl10 (C-X-C motif chemokine ligand 10) [NCBI Gene 15945] {aka C7, CRG-2, INP10, IP-10, IP10, Ifi10}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, FOXC1 (forkhead box C1) [NCBI Gene 2296] {aka ARA, ASGD3, FKHL7, FREAC-3, FREAC3, IGDA}, CCL1 (C-C motif chemokine ligand 1) [NCBI Gene 6346] {aka I-309, P500, SCYA1, SISe, TCA3}, Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 20296] {aka HC11, JE, MCAF, MCP-1, MCP1, SMC-CF}, KRT1 (keratin 1) [NCBI Gene 3848] {aka AEI2, CK1, EHK, EHK1, EPPK, K1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Il1a (interleukin 1 alpha) [NCBI Gene 16175] {aka Il-1a}, Rdh10 (retinol dehydrogenase 10 (all-trans)) [NCBI Gene 98711] {aka 3110069K09Rik, 4921506A21Rik, D1Ertd762e, m366Asp}, MKI67 (marker of proliferation Ki-67) [NCBI Gene 4288] {aka KIA, MIB-, MIB-1, PPP1R105}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, RBP1 (retinol binding protein 1) [NCBI Gene 5947] {aka CRABP-I, CRBP, CRBP1, CRBPI, RBPC, hCRBP1}, SNAI1 (snail family transcriptional repressor 1) [NCBI Gene 6615] {aka SLUGH2, SNA, SNAH, SNAIL, SNAIL1, dJ710H13.1}, CXCL1 (C-X-C motif chemokine ligand 1) [NCBI Gene 2919] {aka FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3}, CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348] {aka G0S19-1, LD78, LD78ALPHA, MIP-1-alpha, MIP1A, SCI}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, Cxcl1 (C-X-C motif chemokine ligand 1) [NCBI Gene 14825] {aka Fsp, Gro1, KC, Mgsa, N51, Scyb1}, KRT13 (keratin 13) [NCBI Gene 3860] {aka CK13, K13, WSN2}, IL1RN (interleukin 1 receptor antagonist) [NCBI Gene 3557] {aka CRMO2, DIRA, ICIL-1RA, IL-1RN, IL-1ra, IL-1ra3}, ALDH3A1 (aldehyde dehydrogenase 3 family member A1) [NCBI Gene 218] {aka ALDH3, ALDHIII}, FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, ALDH3B1 (aldehyde dehydrogenase 3 family member B1) [NCBI Gene 221] {aka ALDH4, ALDH7}, FOXD3 (forkhead box D3) [NCBI Gene 27022] {aka AIS1, Genesis, HFH2, VAMAS2}, MAPK3 (mitogen-activated protein kinase 3) [NCBI Gene 5595] {aka ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1}, ADH7 (alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide) [NCBI Gene 131], IL9 (interleukin 9) [NCBI Gene 3578] {aka HP40, IL-9, P40}, PITX2 (paired like homeodomain 2) [NCBI Gene 5308] {aka ARP1, ASGD4, Brx1, IDG2, IGDS, IGDS2}, RDH10 (retinol dehydrogenase 10) [NCBI Gene 157506] {aka SDR16C4}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, CYP1B1 (cytochrome P450 family 1 subfamily B member 1) [NCBI Gene 1545] {aka ASGD6, CP1B, CYPIB1, GLC3A, P4501B1}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, CCL11 (C-C motif chemokine ligand 11) [NCBI Gene 6356] {aka SCYA11}, KRT3 (keratin 3) [NCBI Gene 3850] {aka CK3, K3, MECD2}, Cxcl15 (C-X-C motif chemokine ligand 15) [NCBI Gene 20309] {aka Il8, Scyb15, lungkine, weche}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, TRIM44 (tripartite motif containing 44) [NCBI Gene 54765] {aka AN3, DIPB, HSA249128, MC7}, KRT19 (keratin 19) [NCBI Gene 3880] {aka CK19, K19, K1CS}, SPINK7 (serine peptidase inhibitor Kazal type 7) [NCBI Gene 84651] {aka ECG2, ECRG2}, FOSL2 (FOS like 2, AP-1 transcription factor subunit) [NCBI Gene 2355] {aka ACED, FRA2}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, STRA6 (signaling receptor and transporter of retinol STRA6) [NCBI Gene 64220] {aka MCOPCB8, MCOPS9, PP14296, SLC69A1}, Aldh1a2 (aldehyde dehydrogenase family 1, subfamily A2) [NCBI Gene 19378] {aka Aldh1a7, Raldh1, Raldh2}
- **Diseases:** developmental defects (MESH:D000094602), inflammatory degeneration (MESH:D009410), injury to (MESH:D014947), cataract (MESH:D002386), foveal and optic nerve underdevelopment (MESH:D000080344), anterior segment dysgenesis (MESH:C537775), Inflammatory (MESH:D007249), pLECs (MESH:D009375), fibrosis (MESH:D005355), RA (MESH:D001172), basal-like breast cancer (MESH:D001943), metastasis (MESH:D009362), triple-negative breast cancer (MESH:D064726), MECD (MESH:D053559), nystagmus (MESH:D009759), corneal neovascularization (MESH:D016510), systemic abnormalities (MESH:D015619), iris hypoplasia (MESH:D007499), tumorigenesis (MESH:D063646), dental and hearing defects (MESH:D034381), ocular disorder (MESH:D005128), hydrocephalus (MESH:D006849), corneal ulcerations (MESH:D003320), ARS (OMIM:616459), cancer (MESH:D009369), LSCD (MESH:D000092423), Axenfeld-Rieger syndrome (MESH:C535679), central nervous system abnormalities (MESH:D063647), neural crest-related malformations (MESH:C536408), AAK (MESH:D015783)
- **Chemicals:** KGM3 medium (-), RA (MESH:D011883), water (MESH:D014867), CO2 (MESH:D002245), SYBR Green (MESH:C098022), LPS (MESH:D008070), Retinoic Acid (MESH:D014212), Retinoid (MESH:D012176), retinol (MESH:D014801), agarose (MESH:D012685), Lipofectamine (MESH:C086724), PBS (MESH:D007854), CaCl2 (MESH:D002122), Tween-20 (MESH:D011136), 3,3',5,5'-tetramethylbenzidine (MESH:C021758), SDS (MESH:D012967), glucose (MESH:D005947), GlutaMAX (MESH:C054122), H2SO4 (MESH:C033158)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** W152G
- **Cell lines:** HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940945/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940945/full.md

## References

51 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940945/full.md

---
Source: https://tomesphere.com/paper/PMC12940945